Angion Biomedica Competitors and Similar CompaniesClear all
Angion Biomedica's competitors and similar companies include Pliant Therapeutics, Complexa, AltaThera Pharmaceuticals and Verrica Pharmaceuticals.
 Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. |  Pliant Therapeutics Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases. |  Complexa Complexa is a biopharmaceutical company, developing therapies for the treatment of inflammatory, and metabolic diseases. |  Verrica Pharmaceuticals Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. | ||
Founding Date | Founding Date 1998 | Founding Date 2016 | Founding Date 2008 | Founding Date 2009 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations San Francisco, US HQ Uniondale, US | Locations South San Francisco, US HQ | Locations Berwyn, US HQ | Locations Chicago, US HQ | Locations West Chester, US HQ |
Employees | Employees 205% increase | Employees 1519% decrease | Employees 9 | Employees 462% increase | Employees 176% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $35.6m (FY, 2025) |
Net income | Net income ($38.8m) (FY, 2022) | Net income N/A | Net income N/A | Net income N/A | Net income ($17.9m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 15.4m (almost 8 years ago) | Latest funding round $ 62m (almost 8 years ago) | Latest funding round $ 62m (almost 9 years ago) | Latest funding round $ 1m (almost 11 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 19.7m | Total funding raised $ 107m | Total funding raised $ 79m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pliant Therapeutics
HQ
South San Francisco, US
Employees
151↓ 9% decrease
Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases.
View companyComplexa
HQ
Berwyn, US
Employees
9
Complexa is a biopharmaceutical company, developing therapies for the treatment of inflammatory, and metabolic diseases.
View company
AltaThera Pharmaceuticals
HQ
Chicago, US
Employees
46↑ 2% increase
AltaThera Pharmaceuticals is a hospital-focused pharmaceutical company.
View companyVerrica Pharmaceuticals
HQ
West Chester, US
Employees
17↑ 6% increase
Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum.
View company